Importance More than 1 billion people worldwide have vision impairment or blindness from
potentially preventable or correctable causes. Quality of life, an important measure of …

Intraocular/Intravitreal implants constitute a relatively new method to treat eye diseases
successfully due to the possibility of releasing drugs in a controlled and prolonged way. This …

Purpose To assess the safety and efficacy of an intravitreal fluocinolone acetonide (FA)
insert to manage inflammation associated with chronic noninfectious posterior uveitis …

There has been steady progress in understanding the pathogenesis, clinical features, and
effective treatment of acute anterior uveitis (AU) over the past 5 years. Large gene wide …

Glaucoma is a multifactorial neurodegenerative disorder and one of the leading causes of
irreversible blindness globally and for which intraocular pressure is the only modifiable risk …

Management of postoperative bacterial endophthalmitis was explored in the
Endophthalmitis Vitrectomy Study 37 in 1995, which has underpinned the core protocols in …

Abstract Background Qinghuo Rougan Formula (QHRGF) is a traditional Chinese medicine
(TCM) that has been widely apllied to treat uveitis for several decades. However, the …

The projected number of people who will develop age-related macular degeneration in
estimated at 2020 is 196 million and is expected to reach 288 million in 2040. Also, the …

Purpose To evaluate the association of systemic immune-inflammation index (SII) levels,
neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) with severity of …

The in vitro drug release in an aqueous medium is a critical performance metric for a
sustained release drug product. During long-term release studies, drugs may degrade in the …